How many insider trades does FilingIQ track for MTNB?

FilingIQ tracks 133 Form 4 insider transactions for MTNB (Matinas BioPharma Holdings, Inc.), covering filings from Mar 15, 2017 onwards. 9 of those were filed in the last 90 days.

Are MTNB insiders net buyers or net sellers?

Across the full Form 4 history for MTNB, 28 transactions (21%) were open-market purchases and 0 (0%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does MTNB insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is MTNB in?

Matinas BioPharma Holdings, Inc. (MTNB) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $4.03M.

MTNB insider trading

NYSE American Healthcare

Matinas BioPharma Holdings, Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

133

Last 90 days

Buys / sells

21% / 0%

Market cap

$4.03M

About Matinas BioPharma Holdings, Inc.

Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company, identifies and develops pharmaceutical products using its lipid nanocrystal (LNC) platform technology. The company's LNC delivery technology platform utilizes lipid nanocrystals for the delivery of small molecules, nucleic acids, gene therapies, vaccines, proteins, and peptides. Its lead product candidate is MAT2203, an oral formulation of amphotericin B that is starting Phase 3 clinical trials for the treatment of aspergillosis and cryptococcosis, as well as prevention of invasive fungal infections in patients due to immunosuppressive therapy. It offers MAT2501, an orally administered formulation of amikacin. The company has strategic collaborations with the National Institute of Allergy and Infectious Diseases; BioNTech SE to evaluate the combination of mRNA formats with the LNC platform; and Genentech Inc. to develop oral formulations. The company was incorporated in 2013 and is based in Bedminster, New Jersey.

Company website: www.matinasbiopharma.com

MTNB insider activity at a glance

FilingIQ has scored 133 insider transactions for MTNB since Mar 15, 2017. The most recent filing in our index is dated Jul 10, 2026.

Across the full history, 28 open-market purchases and 0 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on MTNB insider trades is 58.7/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live MTNB trades on FilingIQ Raw filings on SEC EDGAR

Other Healthcare tickers with recent insider activity

UTHR 983

UNITED THERAPEUTICS Corp

NUVL 195

Nuvalent, Inc.

KYMR 193

Kymera Therapeutics, Inc.

GH 192

Guardant Health, Inc.

Hims & Hers Health, Inc.

Frequently asked

How many insider trades does FilingIQ track for MTNB?: FilingIQ tracks 133 Form 4 insider transactions for MTNB (Matinas BioPharma Holdings, Inc.), covering filings from Mar 15, 2017 onwards. 9 of those were filed in the last 90 days.
Are MTNB insiders net buyers or net sellers?: Across the full Form 4 history for MTNB, 28 transactions (21%) were open-market purchases and 0 (0%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does MTNB insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is MTNB in?: Matinas BioPharma Holdings, Inc. (MTNB) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $4.03M.

Methodology & sources

Every MTNB insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.